Company / Goodwill
TEVA PHARMACEUTICAL INDUSTRIES LTD Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$16.0B
FY2025
5-year range
$15.1B / $17.6B
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#7 of 75
Health Care
What the data says
Among 75 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 9% for goodwill. Declined from $17.2B to $16.0B over the past 2 years.
Based on SEC 10-K filings.
$16.0B in FY2025 with a 5-year CAGR of -5.0%. Top quartile in the Health Care sector.
Declined from $17.2B to $16.0B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -2.3%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 75This company $16.0B Sector average $4.0B
▼
+303.7% above sector average
Key checks
Key Insights
- 5-year CAGR of -5.0%, indicating a declining trend.
- In FY2025, goodwill increased 5.6% year-over-year.
- Ranks #7 out of 75 companies in the Health Care sector.
- Peak goodwill was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.0B | +5.6% |
| FY2024 | $15.1B | -11.8% |
| FY2023 | $17.2B | +0.0% |
| FY2022 | $17.2B | -2.6% |
| FY2021 | $17.6B | -14.5% |
| FY2020 | $20.6B | -17.0% |
| FY2019 | $24.8B | -0.3% |
| FY2018 | $24.9B | -12.3% |
| FY2017 | $28.4B | -36.0% |
| FY2016 | $44.4B | +133.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026